NCT02202980 - Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection | Biotech Hunter

Enrollment

273

Participants

Timeline

Start Date

August 4, 2014

Primary Completion Date

March 16, 2016

Study Completion Date

May 9, 2016

Conditions

Chronic Hepatitis C

Interventions

DRUG

LDV/SOF

90/400 mg FDC tablet administered orally once daily

DRUG

RBV

Tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)

DRUG

SOF/VEL

400/100 mg FDC tablet administered orally once daily

DRUG

VOX

100 mg tablet administered orally once daily with food

Trial Locations (2)

Unknown

Auckland

Christchurch